A Clinical Observation of Liver Fiber Mixture Combined with Adefovir Dipivoxil Capsules in Treatment of Qi-stagnancy and Blood Stasis Type Hepatitis with Hepatic Fibrosis

Abstract:

Objective: Explore soft liver chemical fiber mixture joint adefovir capsule on the clinical effect of qi-stagnancy and blood stasis type liver fibrosis. Method: The treatment group 82 examples using soft liver chemical fiber mixture joint adefovir capsule treatment; the control group 82 patients taking adefovir capsule and other conventional protect liver drugs. After 12 months observation serum immunology and the ultrasonic index index. Result: After treatment, the treatment group patients with liver function index, liver fibrosis indexes and ultrasonics index significantly lower than the control group, the difference was statistically significant. Conclusion: Soft liver fiber mixture combined with adefovir dipivoxil capsules can improve liver fibrosis and ultrasonic liver function, qi-stagnancy and blood stasis type hepatitis B liver fibrosis indexes, with treatment and reversing hepatic fibrosis.